Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Tracy, Stockley"'
Autor:
Don Husereau, Yvonne Bombard, Tracy Stockley, Michael Carter, Scott Davey, Diana Lemaire, Erik Nohr, Paul Park, Alan Spatz, Christine Williams, Aaron Pollett, Bryan Lo, Stephen Yip, Soufiane El Hallani, Harriet Feilotter
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9660-9669 (2023)
Genome-based testing in oncology is a rapidly expanding area of health care that is the basis of the emerging area of precision medicine. The efficient and considered adoption of novel genomic medicine testing is hampered in Canada by the fragmented
Externí odkaz:
https://doaj.org/article/337f4ff3cbac4b7dacc0827507ae3f62
Autor:
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, Neesha C. Dhani, Waldo Jimenez, Stephen Welch, Helen MacKay, Josee-Lyne Ethier, Lucy Gilbert, Xuan Li, Angela Rodriguez, Lucy Chan, Valerie Bowering, Blaise Clarke, Tong Zhang, Ian King, Gregory Downs, Tracy Stockley, Lisa Wang, Smitha Udagani, Amit M. Oza, Stephanie Lheureux
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-11 (2023)
Treatment options in patients with recurrent endometrial carcinoma (EC) are limited and response rates to chemotherapy are poor. Here the authors report the results of a phase II trial of niraparib (PARP inhibitor) monotherapy or in combination with
Externí odkaz:
https://doaj.org/article/996af268f73e4c3ab512d6bbc02ef4fa
Autor:
Geoffrey Liu, Winson Y. Cheung, Harriet Feilotter, Jackie Manthorne, Tracy Stockley, ManTek Yeung, Daniel J. Renouf
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7257-7271 (2022)
Canada’s healthcare system, like others worldwide, is immersed in a process of evolution, attempting to adapt conventional frameworks of health technology assessment (HTA) and funding models to a new landscape of precision medicine in oncology. In
Externí odkaz:
https://doaj.org/article/3abca506a0434ec19f05cd8041852f81
Autor:
Dennis D. H. Kim, Igor Novitzky Basso, Taehyung Simon Kim, Seong Yoon Yi, Kyoung Ha Kim, Tracy Murphy, Steven Chan, Mark Minden, Ivan Pasic, Wilson Lam, Arjun Law, Fotios V. Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey Lipton, Rajat Kumar, Stanley W. K. Ng, Tracy Stockley, Tong Zhang, Ian King, Jonas Mattsson, Jean C. Y. Wang
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 873-884 (2022)
Abstract A 17‐gene stemness (LSC17) score determines risk in acute myeloid leukaemia patients treated with standard chemotherapy regimens. The present study further analysed the impact of the LSC17 score at diagnosis on outcomes following allogenei
Externí odkaz:
https://doaj.org/article/369a826fb44c40558e7eed079916d481
Autor:
Tracy Murphy, Jinfeng Zou, Andrea Arruda, Ting Ting Wang, Zhen Zhao, Yangqiao Zheng, Vikas Gupta, Dawn Maze, Caroline McNamara, Mark D. Minden, Aaron Schimmer, Hassan Sibai, Karen Yee, Jose-Mario Capo-Chichi, Tracy Stockley, Andre Schuh, Scott V. Bratman, Steven M. Chan
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/163cd9b71d294983ad8ccc01a42dae00
Autor:
Schnell D'Souza, Gregory Downs, Shawn Hendrikx, Rouhi Fazelzad, Gabriel Boldt, Karen Burns, Darlene Chapman, Declan Dawes, Antonia Giannarakos, Lori Oja, Risa Schorr, Maureen Babb, Amada Hodgson, Jessica McEwan, Pamela Jacobs, Tracy Stockley, Tim Tripp, Ian King
Publikováno v:
Journal of the Medical Library Association, Vol 111, Iss 1/2 (2023)
Objective: Medical care for cancer is increasingly directed by genomic laboratory testing for alterations in the tumor genome that are significant for diagnosis, prognosis and therapy. Uniquely in medicine, providers must search the biomedical litera
Externí odkaz:
https://doaj.org/article/9425d24bd89f4a2fa9d9e347d0cc3267
Autor:
Miguel Garcia-Pardo, Kasia Czarnecka, Jennifer H. Law, Alexandra Salvarrey, Roxanne Fernandes, Jason Fan, Lucy Corke, Thomas K. Waddell, Kazuhiro Yasufuku, Laura L. Donahoe, Andrew Pierre, Lisa W. Le, Noor Ghumman, Geoffrey Liu, Frances A. Shepherd, Penelope Bradbury, Adrian Sacher, Tracy Stockley, Prodipto Pal, Patrik Rogalla, Ming Sound Tsao, Natasha B. Leighl
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Introduction: Molecular profiling of tumor tissue is the gold standard for treatment decision-making in advanced non-small cell lung cancer (NSCLC). Results may be delayed or unavailable due to insufficient tissue, prolonged wait times for biopsy, pa
Externí odkaz:
https://doaj.org/article/6d16f75f675e4c909e12ca7dabb73091
Autor:
Shamini Selvarajah, PhD, Sophie Plante, MSc, Marsha Speevak, PhD, Andrea Vaags, PhD, Darren Hamelinck, MSc, Martin Butcher, MSc, Elizabeth McCready, PhD, Daria Grafodatskaya, PhD, Normand Blais, MD, Danh Tran-Thanh, MD, Xiaoduan Weng, MD, Rami Nassabein, MD, Wenda Greer, PhD, Ryan N. Walton, MPH, Bryan Lo, MD, Doug Demetrick, MD, Stephanie Santos, BSc, Bekim Sadikovic, PhD, Xiao Zhang, BSc, MSc, Tong Zhang, MD, Tara Spence, PhD, Tracy Stockley, PhD, Harriet Feilotter, PhD, Philippe Joubert, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100212- (2021)
Introduction: Genotyping circulating tumor DNA (ctDNA) is a promising noninvasive clinical tool to identify the EGFR T790M resistance mutation in patients with advanced NSCLC with resistance to EGFR inhibitors. To facilitate standardization and clini
Externí odkaz:
https://doaj.org/article/4343799e3fbf40999e9a88df77f2790e
Autor:
Tracy Murphy, Jinfeng Zou, Georgina S. Daher-Reyes, Andrea Arruda, Vikas Gupta, Caroline J. McNamara, Mark D. Minden, Aaron D. Schimmer, Hassan Sibai, Karen W.L. Yee, Mariam Korulla, Tracy Stockley, Suzanne Kamel-Reid, Dawn Maze, Anne Tierens, Scott V. Bratman, Andre C. Schuh, Steven M. Chan
Publikováno v:
Blood Advances, Vol 3, Iss 15, Pp 2307-2311 (2019)
Externí odkaz:
https://doaj.org/article/8cc7227eb54f49fdb7a858196084e553
Autor:
Aoife J McCarthy, Jose‐Mario Capo‐Chichi, Tara Spence, Sylvie Grenier, Tracy Stockley, Suzanne Kamel‐Reid, Stefano Serra, Peter Sabatini, Runjan Chetty
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 5, Iss 2, Pp 115-129 (2019)
Abstract Immunohistochemistry (IHC) for mismatch repair (MMR) proteins is used to identify MMR status: being diffusely positive (intact/retained nuclear staining) or showing loss of nuclear tumour staining (MMR protein deficient). Four colonic adenoc
Externí odkaz:
https://doaj.org/article/1592df32ccff4a2a8f66c62e89796520